MedPath

To Assess the of efficacy of injectable Hyaluronic Acid filler in augmentation of peri-implant soft tissue.

Not Applicable
Conditions
Health Condition 1: K056- Periodontal disease, unspecified
Registration Number
CTRI/2023/06/053517
Lead Sponsor
VSPM DCRC Digdoh Hills Hingna Road Nagpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Systemically healthy patients

2.Patient with healthy and stable soft tissue architecture

3.Patients with 1 implant placed with functional restoration with keratinized mucosa < 1mm , who were able to maintain oral hygiene around dental implants.

4.Patients with thin gingival phenotype

5.Co-operative, motivated and hygiene conscious patients.

6.Peri-implant probing depth <3mm

7.No signs of pre-exsisting peri-implantitis.

Exclusion Criteria

1.Patients with systemic diseases that would have influenced bone or soft tissue metabolism

2.Pregnant or lactating females

3.Tobacco smokers

4.Uncontrolled medical conditions precluding elective surgery

5.Untreated periodontal conditions

6.Patients treated with any medication known to cause gingival hyperplasia

7.Drug and alcohol abuse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gingival Augmnetation around peri-implant soft tissue.Timepoint: baseline- 3 months- 6 months
Secondary Outcome Measures
NameTimeMethod
1.Plaque index <br/ ><br>2.Gingival index <br/ ><br>3.Modified sulcular bleeding index <br/ ><br>4.Probing depth (PD) <br/ ><br>5.Clinical attachment level (CAL) <br/ ><br>6.Gingival thickness (GT) <br/ ><br>7.Keratinized Tissue width <br/ ><br>8.Interproximal width (IPW) <br/ ><br>9.Papillary Recession depth <br/ ><br>10. Patient Reported Outcome Measures- VAS score scale. <br/ ><br>Timepoint: baseline-3 months- 6 months
© Copyright 2025. All Rights Reserved by MedPath